Are hemostatic agents effective in the treatment of acute spontaneous intracerebral hemorrhage?

Annals of Emergency Medicine
Andrew Worster

Abstract

Methods The investigators searched the Cochrane Stroke Group Trials and Central Register of Controlled Trials, MEDLINE (from 1966), EMBASE (from 1980), bibliographies of relevant articles, and clinical trial registries. Authors and pharmaceutical companies were contacted for clarification and to identify any additional studies. Randomized controlled trials with clinical outcome measures evaluating all doses and administration routes of single or multiple hemostatic agents, including antifibrinolytics, blood coagulation factors, and platelet activators. All trials were assessed for randomization and concealment of treatment allocation and blinded assessment of outcome. Heterogeneity was measured with the Inconsistency Index (I²) statistic. Results including 95% confidence intervals are presented as relative risk for dichotomous outcomes and as mean difference for continuous data; estimates were based on a fixed-effect or random-effects model.

References

May 20, 2005·The New England Journal of Medicine·Jan O Friedrich
Apr 26, 2006·Neurology·S M DavisUNKNOWN Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators
May 16, 2008·The New England Journal of Medicine·Stephan A MayerUNKNOWN FAST Trial Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Thorsten SteinerMichael C Christensen
The American Journal of Emergency Medicine
Jan C PurruckerRoland Veltkamp
© 2021 Meta ULC. All rights reserved